Pharmacopeia Names New Software Unit, Launches Consulting Service | GenomeWeb

NEW YORK, April 2 – Pharmacopeia announced that it has merged its software subsidiaries into a new unit named Accelrys, which will begin operating as a separate unit on June 1.

The four subsidiaries, Molecular Simulations, Synopsys Scientific Systems, Oxford Molecular, and the Genetics Computer Group, had pro forma revenues of more than $90 million in 2000, or 76 percent of Pharmacopeia’s overall revenues of $119 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.